Farmak’s Chief Strategy Officer speaks at Forbes CFO Forum

Dina Nemyrovych, Chief Strategy Officer at Farmak JSC spoke at Forbes CFO Forum held in Fa...

Nov 11, 2013

Farmak has expanded No-Sol line of nasal preparations

Farmak has expanded the No-Sol line. Domestic pharmaceutical manufacturer specialists have...

Nov 04, 2013

Farmak has started marketing the herbal nasal drug Pinovit

Specialists of the domestic pharmaceutical company Farmak have developed and brought to ma...

Oct 29, 2013

Farmak has expanded Moleskin line of dermatological products

Farmak has supplemented the Moleskin dermatological line. Domestic pharmaceutical manufact...

Oct 22, 2013

Farmak has developed an anti-inflammatory drug product Betaspan® Depo

Farmak specialists have developed and brought to market a corticosteroid Betaspan® Depo. T...

Oct 18, 2013

Farmak’s portfolio has added the antifungal drug Lamicon Dermgel

Farmak, the leader in the domestic pharmaceutical market, has expanded the Lamicon antifun...

Oct 14, 2013

Farmak JSC expanded Vasopro product line

Farmak JSC, a leader of pharmaceutical market, has expanded the line of drugs for treatmen...

Oct 07, 2013

Farmak JSC added a word “moisturizing” to the name of No-Sol

Emphasizing the moisturizing effect of No-Sol nasal drug, Farmak’s experts have added a wo...

Oct 03, 2013

Arfa Combi: Treatment of Diabetes

At the end of summer, Farmak JSC launched Arfa Combi, a drug for comprehensive treatment o...

Sep 27, 2013
Show more